Clinical Trials Directory

Trials / Completed

CompletedNCT06868368

Perceptions of Vaping Products

Perceptions of Vaping Products Among Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
21 Years – 34 Years
Healthy volunteers
Accepted

Summary

This clinical trial studies the effects, appeal, and abuse liability of 6-methyl nicotine (metatine) electronic cigarettes among young adults.

Detailed description

PRIMARY OBJECTIVES: I. Assess the pharmacokinetics of metatine and nicotine electronic (e)-cigarettes. II. Assess the abuse liability and appeal of commercial e-cigarettes containing metatine versus nicotine. III. Determine the impact of metatine on e-cigarette puffing behavior (topography). OUTLINE: Participants attend 3 sessions where they will be randomized to 1 of 3 types of e-cigarette. Participants will use the e-cigarette ad-libitum for 30 minutes and answer survey questions about their perceptions of the e-cigarette. Participants must also undergo 4 blood draws during the vaping session.

Conditions

Interventions

TypeNameDescription
OTHERBiospecimen CollectionUndergo blood sample collection
OTHERSurvey AdministrationComplete Surveys
BEHAVIORALVaping TopographyUse e-cigarette connected to a topography device
OTHERParticipant's Own Preferred E-cigaretteParticipant vapes their own preferred e-cigarette for 30 minutes
OTHERNicotine E-cigaretteParticipant vapes a commercially available nicotine e-cigarette for 30 minutes
OTHER6-methyl-nicotine (metatine) e-cigaretteParticipant vapes a commercially available metatine e-cigarette for 30 minutes

Timeline

Start date
2025-03-03
Primary completion
2025-11-04
Completion
2025-11-04
First posted
2025-03-10
Last updated
2025-12-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06868368. Inclusion in this directory is not an endorsement.